Our formulation is free of harsh chemicals, parabens, sulfates, or synthetic fillers
10-Year Follow-Up Studies Long-term research sheds light on how Metformin supports weight stability and other health benefits over time
Risks of compounded GLP-1s include: Improper prescriptions Dosing errors Lack of standardization Contamination Misbranding of products The FDA is currently concerned with an increase in cases of unapproved compounded semaglutide and tirzepatide marketed in the U.S., encouraging consumers to be cautious of where they are getting their medications from
The deciding question it poses is whether the theoretical benefit justifies the added cost, complexity, and interaction risk in your particular clinical picture
It doesn't treat or prevent bone loss
In this blog post, we will explore the implications of discontinuing GLP-1 therapy, the importance of lifestyle changes, and the various strategies that can help maintain weight loss after stopping these medications